3-(4-fluorophenyl)-5-(4-methoxyphenyl)isoxazole | 37613-35-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-(4-fluorophenyl)-5-(4-methoxyphenyl)isoxazole
• 英文别名: 3-(p-Fluorphenyl)-5-(p-methoxyphenyl)-isoxazol；3-(4-Fluorophenyl)-5-(4-methoxyphenyl)-1,2-oxazole
• CAS: 37613-35-7
• 化学式: C₁₆H₁₂FNO₂
• 分子量: 269.275
• InChiKey: OFBFFUGHTRBKLM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  35.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(4-fluorophenyl)-5-(4-methoxyphenyl)isoxazole 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 生成 3-(4-Fluorophenyl)-5-(4-hydroxyphenyl)isoxazole
  参考文献：
  名称：

  Synthesis and structure–activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists

  摘要：

  A novel series of 3,5-diarylisoxazole and 3,5-diaryl-1,2,4-oxadiazole IL-8 antagonists has been identified. These compounds exhibit activity in an IL-8 binding assay as well as in a functional assay of IL-8 induced elastase release from neutrophils. In addition, one of the compounds exhibits oral activity in a rat adjuvant arthritis model. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.05.080
• 作为产物：
  描述：

  syn-4-氟苯甲醛肟 在 N-氯代丁二酰亚胺 、 三乙胺 作用下， 以 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 生成 3-(4-fluorophenyl)-5-(4-methoxyphenyl)isoxazole
  参考文献：
  名称：

  Synthesis and structure–activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists

  摘要：

  A novel series of 3,5-diarylisoxazole and 3,5-diaryl-1,2,4-oxadiazole IL-8 antagonists has been identified. These compounds exhibit activity in an IL-8 binding assay as well as in a functional assay of IL-8 induced elastase release from neutrophils. In addition, one of the compounds exhibits oral activity in a rat adjuvant arthritis model. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.05.080

文献信息

• [EN] TOLL-LIKE RECEPTOR SIGNALING INHIBITORS<br/>[FR] INHIBITEURS DE SIGNALISATION DE RÉCEPTEUR DE TYPE TOLL
  申请人：UNIV ILLINOIS

  公开号：WO2019136147A1

  公开（公告）日：2019-07-11

  Di- and triaryl-substituted heteroaromatic compounds have Toll-like receptor inhibitory activity, including at TLR2, TLR4, TLR7, and/or TLR9. Compounds and compositions have applications in the treatment of diseases and conditions mediated by Toll-like receptors and related receptors, such as bacterial sepsis, autoimmune disease, lupus erythematosus, ischemia-reperfusion injury, stroke, metabolic disease, obesity-related metabolic inflammation, gout, and cancer.

  二芳基和三芳基取代的杂环化合物具有Toll样受体抑制活性，包括在TLR2、TLR4、TLR7和/或TLR9上。这些化合物和组合物在治疗由Toll样受体和相关受体介导的疾病和症状方面具有应用，如细菌性败血症、自身免疫疾病、红斑狼疮、缺血再灌注损伤、中风、代谢疾病、与肥胖相关的代谢性炎症、痛风和癌症。
• Beam,C.F. et al., Journal of Heterocyclic Chemistry, 1972, vol. 9, p. 183 - 185
  作者：Beam,C.F. et al.

  DOI：——

  日期：——
• Synthesis and structure–activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists
  作者：Michele A Weidner-Wells、Todd C Henninger、Stephanie A Fraga-Spano、Christine M Boggs、Michele Matheis、David M Ritchie、Dennis C Argentieri、Michael P Wachter、Dennis J Hlasta

  DOI：10.1016/j.bmcl.2004.05.080

  日期：2004.8

  A novel series of 3,5-diarylisoxazole and 3,5-diaryl-1,2,4-oxadiazole IL-8 antagonists has been identified. These compounds exhibit activity in an IL-8 binding assay as well as in a functional assay of IL-8 induced elastase release from neutrophils. In addition, one of the compounds exhibits oral activity in a rat adjuvant arthritis model. (C) 2004 Elsevier Ltd. All rights reserved.